ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,638.94
2.13%
US Tech 100
19,167.20
2.31%
다우존스 지수
41,488.19
1.65%
Bitcoin
84,015.51
0.07%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Jupiter Neurosciences Inc (JUNS) 시세

Jupiter Neurosciences Inc

Jupiter Neurosciences Inc (JUNS)

NASDAQ
0.6119
0.0037
(0.61%)
마감 15 3월 5:00AM
15분 지연
0.60
-0.0119
(-1.94%)
시간외 거래: 8:59AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.60
매수가
0.5903
매도가
0.615
거래량
26,923
0.587251 일간 변동폭 0.63
0.55 52주 범위 19.51
market_cap
19.862M
전일 종가
0.6082
개장가
0.63
최근 거래 시간
1300
@
0.6
(formt)
마지막 거래 시간
재정 규모
US$ 16,338
VWAP
0.606831
평균 볼륨(3m)
551,300
발행 주식
33,103,860
배당수익률
-
주가수익률
-4.08
주당순이익(EPS)
-0.14
매출
-
순이익
-4.78M

Jupiter Neurosciences Inc 정보

Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we pri... Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL¿ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.jupiterneurosciences.com
본부
Wilmington, Delaware, USA
설립됨
-
Jupiter Neurosciences Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker JUNS. The last closing price for Jupiter Neurosciences was US$0.61. Over the last year, Jupiter Neurosciences shares have traded in a share price range of US$ 0.55 to US$ 19.51.

Jupiter Neurosciences currently has 33,103,860 shares in issue. The market capitalisation of Jupiter Neurosciences is US$20.13 million. Jupiter Neurosciences has a price to earnings ratio (PE ratio) of -4.08.

JUNS 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 1월 2025
JUNS (0.61%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 1월 2025
JUNS (0.61%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
24 12월 2024
JUNS (0.61%)

Form 8-K - Current report
Edgar (US Regulatory)
20 12월 2024
JUNS (0.61%)

Form 8-K - Current report
Edgar (US Regulatory)
20 12월 2024
JUNS (0.61%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.02-3.225806451610.620.67250.56011023530.6328206CS
4-0.24-28.57142857140.840.87270.551496070.7011593CS
12-10.17-94.428969359310.7712.81240.555513003.68584224CS
26-3.4-85419.510.555512954.93865755CS
52-3.4-85419.510.555512954.93865755CS
156-3.4-85419.510.555512954.93865755CS
260-3.4-85419.510.555512954.93865755CS

JUNS - Frequently Asked Questions (FAQ)

What is the current Jupiter Neurosciences share price?
The current share price of Jupiter Neurosciences is US$ 0.60
How many Jupiter Neurosciences shares are in issue?
Jupiter Neurosciences has 33,103,860 shares in issue
What is the market cap of Jupiter Neurosciences?
The market capitalisation of Jupiter Neurosciences is USD 20.13M
What is the 1 year trading range for Jupiter Neurosciences share price?
Jupiter Neurosciences has traded in the range of US$ 0.55 to US$ 19.51 during the past year
What is the PE ratio of Jupiter Neurosciences?
The price to earnings ratio of Jupiter Neurosciences is -4.08
What is the reporting currency for Jupiter Neurosciences?
Jupiter Neurosciences reports financial results in USD
What is the latest annual profit for Jupiter Neurosciences?
The latest annual profit of Jupiter Neurosciences is USD -4.78M
What is the registered address of Jupiter Neurosciences?
The registered address for Jupiter Neurosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Jupiter Neurosciences website address?
The website address for Jupiter Neurosciences is www.jupiterneurosciences.com
Which industry sector does Jupiter Neurosciences operate in?
Jupiter Neurosciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M

JUNS Discussion

게시물 보기
swingingRichard swingingRichard 6 일 전
JUNS is running a promotion. Currently being touted by "RedChip" on Bloomberg TV. 
👍️0
tw0122 tw0122 3 월 전
Back down to $11 halt 38% 
👍️0
Invest-in-America Invest-in-America 3 월 전
JUNS: WHERE do you see that 120%??? Is that your price TARGET??? (Etrade, etc.,.shows only 38%.)
👍️0
tw0122 tw0122 3 월 전
$17 +120%
👍️0
Invest-in-America Invest-in-America 3 월 전
JUNS: O.K., sounds fine to me, Homeboy!!
👍️0
tw0122 tw0122 3 월 전
From Saturn off to Jupiter $11.79 + 50%
👍️0
Invest-in-America Invest-in-America 3 년 전
JUNS (IPO):
👍️0
makinezmoney makinezmoney 3 년 전
$JUNS: IPO is launching next week

We are waiting on it.



Jupiter Neurosciences, Inc. has developed the first and only resveratrol product that safely reaches therapeutic levels without GI-side effects creating treatment possibilities in many indications.

https://jupiterneurosciences.com/








GO $JUNS
👍️0
Invest-in-America Invest-in-America 3 년 전
JUNS: Evidently, now ready-to-go on E-Turd, Fidelity, etc.
👍️0
spindog spindog 3 년 전
Ticker hasn’t shown up on E*TRADE yet
👍️0
crudeoil24 crudeoil24 3 년 전
IPO scheduled for February 3, 2022.
👍️0
crudeoil24 crudeoil24 3 년 전
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer’s disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
👍️0

최근 히스토리

NASDAQ
JUNS
Jupiter Neurosciences
ASX
LEX
Lefroy Exploration
NYSE
SYF
Synchrony Financiall
LSE
91XF
Nat.gas.t 37
BIT
UC6GMW
Unicredit Bank
BIT
UC0JF5
Unicredit Bank
NASDAQ
ICAD
Icad
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지